Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aurinia Pharmaceuticals Inc AUPH

Healthcare Biotechnology
Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis... see more

Recent & Breaking News (NDAQ:AUPH)

Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V. — Fundamental Analysis, Key Performance Indications

GlobeNewswire March 13, 2018

Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018

Business Wire February 28, 2018

Aurinia Enhances Research, Development, and Scientific Expertise with the Appointment of Michael Hayden to its Board of Directors

Business Wire February 22, 2018

Aurinia Named Company of the Year by LifeSciences BC

Business Wire February 20, 2018

Aurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness Program

Business Wire February 14, 2018

Aurinia Enhances Commercial and Business Development Expertise with the Appointment of Joseph P. Hagan to its Board of Directors

Business Wire February 8, 2018

Aurinia to Present at Leerink Partners 7th Annual Global Healthcare Conference

Business Wire February 6, 2018

Aurinia Pharmaceuticals Files New Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus

Business Wire January 4, 2018

Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index

Business Wire December 11, 2017

14 Stocks Moving In Tuesday's After-Hours Session

Benzinga.com  November 14, 2017

Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights

Business Wire November 14, 2017

Aurinia Pharmaceuticals Inc. to Host Earnings Call

Accesswire November 14, 2017

Aurinia Pharmaceuticals to Release Third Quarter 2017 Financial Results on November 14, 2017

Business Wire November 6, 2017

Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome

Business Wire October 20, 2017

Aurinia Receives National Corporate Visionary Award from the Lupus Foundation of America

Business Wire October 12, 2017

Breakfast Technical Briefing on Biotech Stocks -- Amicus Therapeutics, Argos Therapeutics, Array BioPharma, and Aurinia Pharma

PR Newswire September 26, 2017

Aurinia to Host R&D Day and Webcast on October 20th in New York, NY

Business Wire September 19, 2017

S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

Canada NewsWire September 8, 2017

Aurinia to Webcast at Upcoming Investor Conferences

Business Wire September 5, 2017

Breakfast Technical Briefing on Biotech Stocks -- Aurinia Pharma, Esperion Therapeutics, Paratek Pharma, and Verastem

PR Newswire July 21, 2017